OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 134 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |